Last edition
News about "vascular endothelial growth factor "
Biocon Biologics Gets FDA Approval for Biosimilar Aflibercept for Yesafili
Biocon Biologics Ltd (BBL) has announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili.
Vascular Endothelial Growth Factor | 21/05/2024 | By Aishwarya | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members